Fig. 5From: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver diseaseCost impact of risk stratification in primary care. Incremental cost expenditure and savings compared to SOC at different stages of the management pathway over a 1-year time horizon for 1000 NAFLD patientsBack to article page